Trenaplex D 100 mg

Trenaplex D 100 mg contains trenbolone hexahydrobenzylcarbonate, an injectable anabolic steroid. It is not approved for human use and is intended for veterinary purposes only. In non-medical bodybuilding contexts, it is commonly referenced for its potent anabolic effects, though such use falls outside approved indications and is illegal.

Due to the long hexahydrobenzylcarbonate ester, trenbolone hexahydrobenzylcarbonate is typically referenced as being administered twice weekly or every two to three days to maintain stable blood levels. This is distinct from the shorter acetate ester, which requires daily or every-other-day injections.

Yes. Trenbolone is profoundly suppressive to the hypothalamic-pituitary-gonadal axis, and post-cycle therapy is commonly recommended after a cycle. Agents such as Clomiplex or Tamoxiplex are commonly referenced for this purpose. Due to the long ester, PCT should typically begin approximately 2 weeks after the final injection.

Trenbolone binds with high affinity to androgen receptors, promoting nitrogen retention and protein synthesis. Unlike testosterone, it does not aromatize to estrogen, which contributes to its reputation for producing lean, dry muscle gains. However, it is a potent progestin and has been associated with significant adverse effects.

Due to the long ester, blood levels accumulate gradually. In bodybuilding discussions, users sometimes report noticeable effects within the first 2–3 weeks of use. Full steady-state effects for the long ester are typically reached by weeks 4–6. Individual response varies considerably.

There is no universally "best" trenbolone ester. Trenbolone hexahydrobenzylcarbonate has a longer half-life than acetate, supporting less frequent injections. Trenbolone acetate has a shorter half-life and clears the system more quickly if side effects occur. The appropriate choice depends on individual goals, injection frequency preference, and tolerance for side effects.

Both are trenbolone esters, but they differ in release rate. Trenbolone hexahydrobenzylcarbonate has a longer half-life, supporting twice-weekly or every-three-day injections. Trenbolone acetate has a shorter half-life of approximately 1–2 days, requiring every-other-day or daily injections. Axiolabs offers Trenaplex A 100 as its trenbolone acetate product.

Trenbolone hexahydrobenzylcarbonate and trenbolone enanthate are closely related long-acting trenbolone esters. Both are designed to slow the release of trenbolone after administration and have broadly comparable characteristics. The hexahydrobenzylcarbonate ester may have a slightly longer half-life. Axiolabs offers Trenaplex E 200 as its trenbolone enanthate product.

In non-medical bodybuilding contexts, 400 mg per week is at the higher end of commonly referenced ranges of 200–400 mg per week. Trenaplex D 100 mg contains 100 mg/mL, so 400 mg would equal 4 mL per week. Due to the severity of side effects, trenbolone is generally considered an advanced compound.

Trenaplex D 100 mg is labeled at 100 mg of trenbolone hexahydrobenzylcarbonate per mL. It is supplied in a 10 mL vial, giving 1,000 mg of total labeled trenbolone hexahydrobenzylcarbonate content per vial.

Lab testing information for Trenaplex D 100 mg is not available on this page. For product-specific testing inquiries, please contact customer support.

Parabolan was the brand name for trenbolone hexahydrobenzylcarbonate, the same active substance in Trenaplex D 100 mg. It was the only trenbolone formulation approved for human medical use, introduced in France in 1980 and discontinued in 1997. Trenaplex D 100 mg contains the same active substance but is not a pharmaceutical product.